Sun.Feb 11, 2024

article thumbnail

The Blood of Exceptionally Long-Lived People Reveals Key Differences

AuroBlog - Aurous Healthcare Clinical Trials blog

Centenarians, once considered rare, have become commonplace. Indeed, they are the fastest-growing demographic group of the world’s population, with numbers roughly doubling every ten years since the 1970s. How long humans can live, and what determines a long and healthy life, have been of interest for as long as we know.

article thumbnail

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

JAMA Internal Medicine

This cohort study investigates which oral antidiabetic drug was associated with the most advantageous outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes.

Drugs 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CDSCO’s new online submission system a game-changer: Experts

AuroBlog - Aurous Healthcare Clinical Trials blog

Regulatory experts and industry captains are of the view that adoption of new online submission systems will be a pathway to efficient and effective processing by the regulatory authorities. This follows after a circular from the deputy drugs controller India’s office to switch over from physical files to e:mode for processing all offline applications.

Drugs 149
article thumbnail

Pfizer/BioNTech COVID jab to be sold privately in UK

pharmaphorum

MHRA license change means people in GB will be able to buy Pfizer’s COVID-19 vaccine Comirnaty at retail pharmacies from March

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Using Artificial Intelligence to Improve Primary Care for Patients and Clinicians

JAMA Internal Medicine

This Viewpoint discusses how artificial intelligence can be used to increase efficiency of primary care processes for clinicians and patients.

81
article thumbnail

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

FDA Law Blog

By Larry K. Houck — With apologies to David Letterman, who introduced the first Top Ten List on Late Night with David Letterman on September 18, 1985, we present “Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not.”* The wide range of assertions supporting or opposing Health and Human Services’ (“HHS’”) recommendation that the Drug Enforcement Administration (“DEA”) reschedule cannabis federally from schedule I to schedule III would lead an outsider to conclude that commenters are